High expression of CBX4 was associated with tumor size, pathologic differentiation and poorer survival of patients, while down-regulation of CBX7 was found to be associated with shorter overall survival (OS) of HCC patients [14,15]. Here, CBX4 is linked to hepatocellular carcinoma.